The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo (Q39748438)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo |
scientific article |
Statements
1 reference
The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo (English)
1 reference
Stephen W Fesik
1 reference
Scott Ackler
1 reference
Michael J Mitten
1 reference
Kelly Foster
1 reference
Anatol Oleksijew
1 reference
Marion Refici
1 reference
Stephen K Tahir
1 reference
Yu Xiao
1 reference
Christin Tse
1 reference
David J Frost
1 reference
Saul H Rosenberg
1 reference
Steven W Elmore
1 reference
Alexander R Shoemaker
1 reference
23 January 2010
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference